Risk of depressive symptoms before and after the first hospitalisation for cancer: Evidence from a 16-year cohort study in the Czech Republic.

Journal of Affective Disorders
Wentian LuMartin Bobak

Abstract

Whether depression risk starts increasing before cancer diagnosis, and whether cancer is an independent risk factor for depression, remain unclear. We aimed to quantify the risk of depressive symptoms before and after the first hospitalisation for cancer (as a proxy for cancer diagnosis) amongst patients with cancer. We linked cohort data with national hospitalisation records in the Czech Republic. We followed 1056 incident cancer cases for up to 15 years before and 15 years after the first hospitalisation for cancer. Depressive symptoms were measured using the Centre for Epidemiological Studies-Depression (CES-D) scale. We used multilevel ordered logistic regression to assess the relationship between follow-up years (pre- and post-hospitalisation) and depressive symptoms amongst incident cancer cases. Propensity Score Matching was employed to match each case with a cancer-free control, to test the independent effect of cancer on depressive symptoms over time. Per one year of follow-up (whether pre- or post- hospitalisation) was associated with 1.07 (1.05-1.10) times more likely to have high severity of depressive symptoms amongst patients with cancer. The probability of having high severity of depressive symptoms increased fro...Continue Reading

References

Mar 14, 1981·Lancet·M G MarmotB J Thomas
Nov 1, 1995·Journal of Clinical Epidemiology·A B Steingart, M Cotterchio
Dec 11, 1997·The New England Journal of Medicine·M J ThunR Doll
Aug 30, 2000·Postgraduate Medical Journal·M Lloyd-Williams
Feb 8, 2005·BMJ : British Medical Journal·Caroline BurgessAmanda Ramirez
Sep 27, 2005·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Graziano OnderLuigi Ferrucci
Oct 17, 2008·Nature·Vaishnav Krishnan, Eric J Nestler
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susanne O DaltonChristoffer Johansen
Mar 31, 2009·International Journal of Cancer. Journal International Du Cancer·Michael E BenrosPreben B Mortensen
Dec 19, 2009·International Journal of Cancer. Journal International Du Cancer·Gustaf EdgrenOlof Nyrén
Mar 9, 2011·Addiction·Joseph M Boden, David M Fergusson
Jan 1, 2010·Journal of Cognition and Development : Official Journal of the Cognitive Development Society·Patrick J CurranDiane Losardo
Mar 2, 2012·BMC Medical Research Methodology·Caroline Bennette, Andrew Vickers
Jun 29, 2012·Biology of Mood & Anxiety Disorders·Berhane MessayAnna L Marsland
Dec 19, 2012·JAMA Psychiatry·Stephen KiselyDavid Lawrence
Oct 5, 2014·The Lancet Oncology·Connie I DiakosStephen J Clarke
Oct 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nis P SuppliSusanne O Dalton
May 17, 2015·Evidence-based Nursing·Roberta Heale, Alison Twycross
Nov 29, 2016·Cancer Treatment Reviews·Beatrice BortolatoAndré F Carvalho
Dec 6, 2016·JAMA Oncology·Donghao LuFang Fang
Dec 6, 2016·JAMA Oncology·Jasmina MalletOlivier Huillard
May 20, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J ZhuU Valdimarsdóttir
Apr 27, 2018·BMJ : British Medical Journal·Alexandra PitmanAndrew Hodgkiss
Nov 6, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jasmina MalletYann Le Strat
Jan 30, 2019·BMJ : British Medical Journal·Dan J SteinMark van Ommeren
Aug 29, 2019·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Annie HerbertGeorgios Lyratzopoulos

❮ Previous
Next ❯

Citations

Feb 16, 2021·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Hadi ZamanianSahar Foroozanfar

❮ Previous
Next ❯

Software Mentioned

Stata SE
HAPIEE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.